Constantine Davides
Stock Analyst at Citizens
(1.05)
# 3,869
Out of 5,090 analysts
115
Total ratings
31.13%
Success rate
-20.44%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $94.51 | +29.09% | 6 | Dec 4, 2025 | |
| EVH Evolent Health | Maintains: Market Outperform | $13 → $11 | $3.94 | +179.19% | 11 | Nov 10, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $23.84 | +30.03% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $14.24 | +68.54% | 11 | Nov 7, 2025 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $16.26 | +47.60% | 12 | Nov 7, 2025 | |
| OPCH Option Care Health | Maintains: Market Outperform | $38 → $36 | $29.89 | +20.44% | 7 | Oct 31, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $34.35 | +39.74% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $113.19 | +32.52% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $19.64 | - | 2 | Jun 18, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $9.22 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.65 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $75.03 | +50.61% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $33.32 | -21.97% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $178.86 | +38.66% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $24.26 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $8.00 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.02 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.23 | +326.83% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.62 | +20,225.20% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $27.81 | -46.06% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $20.74 | +8.49% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.11 | +173.31% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.20 | +1,066.67% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $1.98 | +18,081.82% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.93 | +167,775.65% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $1.13 | +3,439.82% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.30 | +1,902.00% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.58 | +50,532.91% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $2.19 | +227,297.26% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.48 | +17,489.24% | 2 | Sep 23, 2022 |
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $94.51
Upside: +29.09%
Evolent Health
Nov 10, 2025
Maintains: Market Outperform
Price Target: $13 → $11
Current: $3.94
Upside: +179.19%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $23.84
Upside: +30.03%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $14.24
Upside: +68.54%
AMN Healthcare Services
Nov 7, 2025
Maintains: Market Outperform
Price Target: $22 → $24
Current: $16.26
Upside: +47.60%
Option Care Health
Oct 31, 2025
Maintains: Market Outperform
Price Target: $38 → $36
Current: $29.89
Upside: +20.44%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $34.35
Upside: +39.74%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $113.19
Upside: +32.52%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $19.64
Upside: -
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.22
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.65
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $75.03
Upside: +50.61%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $33.32
Upside: -21.97%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $178.86
Upside: +38.66%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $24.26
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $8.00
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $24.02
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.23
Upside: +326.83%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.62
Upside: +20,225.20%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $27.81
Upside: -46.06%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $20.74
Upside: +8.49%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.11
Upside: +173.31%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.20
Upside: +1,066.67%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $1.98
Upside: +18,081.82%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.93
Upside: +167,775.65%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $1.13
Upside: +3,439.82%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.30
Upside: +1,902.00%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.58
Upside: +50,532.91%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $2.19
Upside: +227,297.26%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.48
Upside: +17,489.24%